BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 2010

View Archived Issues

Preclinical activity of LY-S6KAKT1 justifies entry into phase I trial as cancer therapy

Read More

GlaxoSmithKline claims new inhibitors of focal adhesion kinase 1

Read More

High Point Pharma patents new beta-secretase 1 inhibitors

Read More

Roche describes novel inverse agonists of GABA(A) receptor

Read More

Multikinase inhibitor AI-1008 shows promise to treat chronic myeloid leukemia in preclinical testing

Read More

Phase I data presented on MEDI-573 and MEDI-575 in advanced solid tumors

Read More

Pfizer's AadAT inhibitor PF-4859989 shows activity in vivo

Read More

Atrasentan reduces albuminuria in patients with diabetes-associated nephropathy

Read More

Elan presents new antagonists of integrin alpha-4/beta-7

Read More

FDA clears design of phase III oritavancin trials SOLO-1 and -2

Read More

UCB updates progress from third quarter of 2010

Read More

Ohio State University claims new inhibitors of prostaglandin G/H synthase 2

Read More

Immunovaccine and OncoTherapy Science join to develop cancer vaccine

Read More

Renhuang Pharmaceuticals changes name to China Botanic Pharmaceutical

Read More

Optimer Pharma submits NDA for fidaxomicin to FDA and requests priority review

Read More

Pfizer's phase III axitinib trial in renal cell carcinoma meets primary endpoint

Read More

Tamir Biotechnology compounds show encouraging in vitro activity against HPV

Read More

Transition Therapeutics and Elan amend agreement on scyllo-inositol

Read More

Anacor, UCSF and LFKRI team up to discover onchocerciasis therapies

Read More

ACT files IND for phase I/II trial of MA-09-HRPE in dry AMD

Read More

NanoBio receives grant to develop vaccine against RSV infection

Read More

Savient Pharma's Krystexxa is available by prescription in U.S.

Read More

Ikaria begins pivotal phase III Lucassin trial in hepatorenal syndrome type 1

Read More

Accentia forms strategic alliance with Baxter

Read More

CBLB-502 receives FDA orphan drug status for prevention of death following irradiation

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing